Home > > > > Report Detail

Global Clinical Research Organisation (CRO) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 08-Dec-2022
No. of pages: 127
Inquire Before Buying

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Clinical Research Organisation (CRO) estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Clinical Research Organisation (CRO) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Clinical Research Organisation (CRO) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Clinical Research Organisation (CRO) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Clinical Research Organisation (CRO) include Charles River Laboratories, IQVIA, LabCorp, Domainex, Evotec AG, Genscript Biotech, GVK Biosciences, Aurobindo Pharma and Eurofins Scientific, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Clinical Research Organisation (CRO) companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Clinical Research Organisation (CRO) market. Further, it explains the major drivers and regional dynamics of the global Clinical Research Organisation (CRO) market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Charles River Laboratories

- IQVIA

- LabCorp

- Domainex

- Evotec AG

- Genscript Biotech

- GVK Biosciences

- Aurobindo Pharma

- Eurofins Scientific

- Reprocell

- Dalton Pharma

- NovAliX

- Jubilant Biosys

- Lupin Pharmaceuticals

- Piramal Pharma

- Sun Pharmaceutical

- Sai Ganga Panakeia

- Vitas Pharma

- Pharmaron Beijing

- WuXi AppTec

- Asymchem Laboratories

- Porton Pharma

- ChemPartner

- Hangzhou Tigermed

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Clinical Research Organisation (CRO) Segment by Type

- Small molecules

- Biologics

Clinical Research Organisation (CRO) Segment by Application

- Pharmaceutical Company

- Research Institute

- Other

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Clinical Research Organisation (CRO) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Clinical Research Organisation (CRO) market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Clinical Research Organisation (CRO), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Clinical Research Organisation (CRO), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Clinical Research Organisation (CRO) revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Clinical Research Organisation (CRO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Clinical Research Organisation (CRO) revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Charles River Laboratories, IQVIA, LabCorp, Domainex, Evotec AG, Genscript Biotech, GVK Biosciences, Aurobindo Pharma and Eurofins Scientific, etc.

Global Clinical Research Organisation (CRO) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Research Organisation (CRO) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Small molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Clinical Research Organisation (CRO) Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Clinical Research Organisation (CRO) Market Size (2017-2028)
2.2 Clinical Research Organisation (CRO) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Clinical Research Organisation (CRO) Market Size by Region (2017-2022)
2.4 Global Clinical Research Organisation (CRO) Market Size Forecast by Region (2023-2028)
2.5 Global Top Clinical Research Organisation (CRO) Countries Ranking by Market Size
3 Clinical Research Organisation (CRO) Competitive by Company
3.1 Global Clinical Research Organisation (CRO) Revenue by Players
3.1.1 Global Clinical Research Organisation (CRO) Revenue by Players (2017-2022)
3.1.2 Global Clinical Research Organisation (CRO) Market Share by Players (2017-2022)
3.2 Global Clinical Research Organisation (CRO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Clinical Research Organisation (CRO) Revenue
3.4 Global Clinical Research Organisation (CRO) Market Concentration Ratio
3.4.1 Global Clinical Research Organisation (CRO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Research Organisation (CRO) Revenue in 2021
3.5 Global Clinical Research Organisation (CRO) Key Players Head office and Area Served
3.6 Key Players Clinical Research Organisation (CRO) Product Solution and Service
3.7 Date of Enter into Clinical Research Organisation (CRO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Clinical Research Organisation (CRO) Breakdown Data by Type
4.1 Global Clinical Research Organisation (CRO) Historic Revenue by Type (2017-2022)
4.2 Global Clinical Research Organisation (CRO) Forecasted Revenue by Type (2023-2028)
5 Global Clinical Research Organisation (CRO) Breakdown Data by Application
5.1 Global Clinical Research Organisation (CRO) Historic Market Size by Application (2017-2022)
5.2 Global Clinical Research Organisation (CRO) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Clinical Research Organisation (CRO) Revenue by Company (2020-2022)
6.2 North America Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
6.3 North America Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
6.4 North America Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Clinical Research Organisation (CRO) Revenue by Company (2020-2022)
7.2 Europe Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
7.3 Europe Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
7.4 Europe Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Clinical Research Organisation (CRO) Revenue by Company (2020-2022)
8.2 Asia Pacific Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
8.3 Asia Pacific Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
8.4 Asia Pacific Clinical Research Organisation (CRO) Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Clinical Research Organisation (CRO) Revenue by Company (2020-2022)
9.2 Latin America Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
9.3 Latin America Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
9.4 Latin America Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Clinical Research Organisation (CRO) Revenue by Company (2020-2022)
10.2 Middle East and Africa Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
10.3 Middle East and Africa Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
10.4 Middle East and Africa Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Clinical Research Organisation (CRO) Products and Services
11.1.4 Charles River Laboratories Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.1.5 Charles River Laboratories Clinical Research Organisation (CRO) SWOT Analysis
11.1.6 Charles River Laboratories Recent Developments
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Clinical Research Organisation (CRO) Products and Services
11.2.4 IQVIA Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.2.5 IQVIA Clinical Research Organisation (CRO) SWOT Analysis
11.2.6 IQVIA Recent Developments
11.3 LabCorp
11.3.1 LabCorp Company Details
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Clinical Research Organisation (CRO) Products and Services
11.3.4 LabCorp Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.3.5 LabCorp Clinical Research Organisation (CRO) SWOT Analysis
11.3.6 LabCorp Recent Developments
11.4 Domainex
11.4.1 Domainex Company Details
11.4.2 Domainex Business Overview
11.4.3 Domainex Clinical Research Organisation (CRO) Products and Services
11.4.4 Domainex Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.4.5 Domainex Clinical Research Organisation (CRO) SWOT Analysis
11.4.6 Domainex Recent Developments
11.5 Evotec AG
11.5.1 Evotec AG Company Details
11.5.2 Evotec AG Business Overview
11.5.3 Evotec AG Clinical Research Organisation (CRO) Products and Services
11.5.4 Evotec AG Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.5.5 Evotec AG Clinical Research Organisation (CRO) SWOT Analysis
11.5.6 Evotec AG Recent Developments
11.6 Genscript Biotech
11.6.1 Genscript Biotech Company Details
11.6.2 Genscript Biotech Business Overview
11.6.3 Genscript Biotech Clinical Research Organisation (CRO) Products and Services
11.6.4 Genscript Biotech Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.6.5 Genscript Biotech Clinical Research Organisation (CRO) SWOT Analysis
11.6.6 Genscript Biotech Recent Developments
11.7 GVK Biosciences
11.7.1 GVK Biosciences Company Details
11.7.2 GVK Biosciences Business Overview
11.7.3 GVK Biosciences Clinical Research Organisation (CRO) Products and Services
11.7.4 GVK Biosciences Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.7.5 GVK Biosciences Clinical Research Organisation (CRO) SWOT Analysis
11.7.6 GVK Biosciences Recent Developments
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Company Details
11.8.2 Aurobindo Pharma Business Overview
11.8.3 Aurobindo Pharma Clinical Research Organisation (CRO) Products and Services
11.8.4 Aurobindo Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.8.5 Aurobindo Pharma Clinical Research Organisation (CRO) SWOT Analysis
11.8.6 Aurobindo Pharma Recent Developments
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Details
11.9.2 Eurofins Scientific Business Overview
11.9.3 Eurofins Scientific Clinical Research Organisation (CRO) Products and Services
11.9.4 Eurofins Scientific Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.9.5 Eurofins Scientific Clinical Research Organisation (CRO) SWOT Analysis
11.9.6 Eurofins Scientific Recent Developments
11.10 Reprocell
11.10.1 Reprocell Company Details
11.10.2 Reprocell Business Overview
11.10.3 Reprocell Clinical Research Organisation (CRO) Products and Services
11.10.4 Reprocell Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.10.5 Reprocell Clinical Research Organisation (CRO) SWOT Analysis
11.10.6 Reprocell Recent Developments
11.11 Dalton Pharma
11.11.1 Dalton Pharma Company Details
11.11.2 Dalton Pharma Business Overview
11.11.3 Dalton Pharma Clinical Research Organisation (CRO) Products and Services
11.11.4 Dalton Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.11.5 Dalton Pharma Recent Developments
11.12 NovAliX
11.12.1 NovAliX Company Details
11.12.2 NovAliX Business Overview
11.12.3 NovAliX Clinical Research Organisation (CRO) Products and Services
11.12.4 NovAliX Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.12.5 NovAliX Recent Developments
11.13 Jubilant Biosys
11.13.1 Jubilant Biosys Company Details
11.13.2 Jubilant Biosys Business Overview
11.13.3 Jubilant Biosys Clinical Research Organisation (CRO) Products and Services
11.13.4 Jubilant Biosys Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.13.5 Jubilant Biosys Recent Developments
11.14 Lupin Pharmaceuticals
11.14.1 Lupin Pharmaceuticals Company Details
11.14.2 Lupin Pharmaceuticals Business Overview
11.14.3 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Products and Services
11.14.4 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.14.5 Lupin Pharmaceuticals Recent Developments
11.15 Piramal Pharma
11.15.1 Piramal Pharma Company Details
11.15.2 Piramal Pharma Business Overview
11.15.3 Piramal Pharma Clinical Research Organisation (CRO) Products and Services
11.15.4 Piramal Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.15.5 Piramal Pharma Recent Developments
11.16 Sun Pharmaceutical
11.16.1 Sun Pharmaceutical Company Details
11.16.2 Sun Pharmaceutical Business Overview
11.16.3 Sun Pharmaceutical Clinical Research Organisation (CRO) Products and Services
11.16.4 Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.16.5 Sun Pharmaceutical Recent Developments
11.17 Sai Ganga Panakeia
11.17.1 Sai Ganga Panakeia Company Details
11.17.2 Sai Ganga Panakeia Business Overview
11.17.3 Sai Ganga Panakeia Clinical Research Organisation (CRO) Products and Services
11.17.4 Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.17.5 Sai Ganga Panakeia Recent Developments
11.18 Vitas Pharma
11.18.1 Vitas Pharma Company Details
11.18.2 Vitas Pharma Business Overview
11.18.3 Vitas Pharma Clinical Research Organisation (CRO) Products and Services
11.18.4 Vitas Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.18.5 Vitas Pharma Recent Developments
11.19 Pharmaron Beijing
11.19.1 Pharmaron Beijing Company Details
11.19.2 Pharmaron Beijing Business Overview
11.19.3 Pharmaron Beijing Clinical Research Organisation (CRO) Products and Services
11.19.4 Pharmaron Beijing Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.19.5 Pharmaron Beijing Recent Developments
11.20 WuXi AppTec
11.20.1 WuXi AppTec Company Details
11.20.2 WuXi AppTec Business Overview
11.20.3 WuXi AppTec Clinical Research Organisation (CRO) Products and Services
11.20.4 WuXi AppTec Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.20.5 WuXi AppTec Recent Developments
11.21 Asymchem Laboratories
11.21.1 Asymchem Laboratories Company Details
11.21.2 Asymchem Laboratories Business Overview
11.21.3 Asymchem Laboratories Clinical Research Organisation (CRO) Products and Services
11.21.4 Asymchem Laboratories Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.21.5 Asymchem Laboratories Recent Developments
11.22 Porton Pharma
11.22.1 Porton Pharma Company Details
11.22.2 Porton Pharma Business Overview
11.22.3 Porton Pharma Clinical Research Organisation (CRO) Products and Services
11.22.4 Porton Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.22.5 Porton Pharma Recent Developments
11.23 ChemPartner
11.23.1 ChemPartner Company Details
11.23.2 ChemPartner Business Overview
11.23.3 ChemPartner Clinical Research Organisation (CRO) Products and Services
11.23.4 ChemPartner Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.23.5 ChemPartner Recent Developments
11.24 Hangzhou Tigermed
11.24.1 Hangzhou Tigermed Company Details
11.24.2 Hangzhou Tigermed Business Overview
11.24.3 Hangzhou Tigermed Clinical Research Organisation (CRO) Products and Services
11.24.4 Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022)
11.24.5 Hangzhou Tigermed Recent Developments
12 Clinical Research Organisation (CRO) Market Dynamics
12.1 Clinical Research Organisation (CRO) Market Trends
12.2 Clinical Research Organisation (CRO) Market Drivers
12.3 Clinical Research Organisation (CRO) Market Challenges
12.4 Clinical Research Organisation (CRO) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Clinical Research Organisation (CRO) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Small molecules
Table 3. Key Players of Biologics
Table 4. Global Clinical Research Organisation (CRO) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Clinical Research Organisation (CRO) Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Clinical Research Organisation (CRO) Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Clinical Research Organisation (CRO) Revenue Market Share by Region (2017-2022)
Table 8. Global Clinical Research Organisation (CRO) Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Clinical Research Organisation (CRO) Market Share by Players (2017-2022)
Table 10. Global Top Clinical Research Organisation (CRO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Research Organisation (CRO) as of 2021)
Table 11. Ranking of Global Top Clinical Research Organisation (CRO) Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Clinical Research Organisation (CRO) Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Clinical Research Organisation (CRO) Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Clinical Research Organisation (CRO) Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Clinical Research Organisation (CRO) Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Clinical Research Organisation (CRO) Revenue Market Share by Type (2017-2022)
Table 19. Global Clinical Research Organisation (CRO) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Clinical Research Organisation (CRO) Revenue Market Share by Type (2023-2028)
Table 21. Global Clinical Research Organisation (CRO) Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Clinical Research Organisation (CRO) Revenue Market Share by Application (2017-2022)
Table 23. Global Clinical Research Organisation (CRO) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Clinical Research Organisation (CRO) Revenue Market Share by Application (2023-2028)
Table 25. North America Clinical Research Organisation (CRO) Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Clinical Research Organisation (CRO) Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Clinical Research Organisation (CRO) Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Clinical Research Organisation (CRO) Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Clinical Research Organisation (CRO) Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Clinical Research Organisation (CRO) Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Clinical Research Organisation (CRO) Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (US$ Million)
Table 60. Charles River Laboratories Company Details
Table 61. Charles River Laboratories Business Overview
Table 62. Charles River Laboratories Clinical Research Organisation (CRO) Product and Services
Table 63. Charles River Laboratories Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 64. Charles River Laboratories Clinical Research Organisation (CRO) SWOT Analysis
Table 65. Charles River Laboratories Recent Developments
Table 66. IQVIA Company Details
Table 67. IQVIA Business Overview
Table 68. IQVIA Clinical Research Organisation (CRO) Product and Services
Table 69. IQVIA Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 70. IQVIA Clinical Research Organisation (CRO) SWOT Analysis
Table 71. IQVIA Recent Developments
Table 72. LabCorp Company Details
Table 73. LabCorp Business Overview
Table 74. LabCorp Clinical Research Organisation (CRO) Product and Services
Table 75. LabCorp Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 76. LabCorp Clinical Research Organisation (CRO) SWOT Analysis
Table 77. LabCorp Recent Developments
Table 78. Domainex Company Details
Table 79. Domainex Business Overview
Table 80. Domainex Clinical Research Organisation (CRO) Product and Services
Table 81. Domainex Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 82. Domainex Clinical Research Organisation (CRO) SWOT Analysis
Table 83. Domainex Recent Developments
Table 84. Evotec AG Company Details
Table 85. Evotec AG Business Overview
Table 86. Evotec AG Clinical Research Organisation (CRO) Product and Services
Table 87. Evotec AG Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 88. Evotec AG Clinical Research Organisation (CRO) SWOT Analysis
Table 89. Evotec AG Recent Developments
Table 90. Genscript Biotech Company Details
Table 91. Genscript Biotech Business Overview
Table 92. Genscript Biotech Clinical Research Organisation (CRO) Product and Services
Table 93. Genscript Biotech Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 94. Genscript Biotech Clinical Research Organisation (CRO) SWOT Analysis
Table 95. Genscript Biotech Recent Developments
Table 96. GVK Biosciences Company Details
Table 97. GVK Biosciences Business Overview
Table 98. GVK Biosciences Clinical Research Organisation (CRO) Product and Services
Table 99. GVK Biosciences Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 100. GVK Biosciences Clinical Research Organisation (CRO) SWOT Analysis
Table 101. GVK Biosciences Recent Developments
Table 102. Aurobindo Pharma Company Details
Table 103. Aurobindo Pharma Business Overview
Table 104. Aurobindo Pharma Clinical Research Organisation (CRO) Product and Services
Table 105. Aurobindo Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 106. Aurobindo Pharma Clinical Research Organisation (CRO) SWOT Analysis
Table 107. Aurobindo Pharma Recent Developments
Table 108. Eurofins Scientific Company Details
Table 109. Eurofins Scientific Business Overview
Table 110. Eurofins Scientific Clinical Research Organisation (CRO) Product and Services
Table 111. Eurofins Scientific Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 112. Eurofins Scientific Clinical Research Organisation (CRO) SWOT Analysis
Table 113. Eurofins Scientific Recent Developments
Table 114. Reprocell Company Details
Table 115. Reprocell Business Overview
Table 116. Reprocell Clinical Research Organisation (CRO) Product and Services
Table 117. Reprocell Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 118. Reprocell Clinical Research Organisation (CRO) SWOT Analysis
Table 119. Reprocell Recent Developments
Table 120. Dalton Pharma Company Details
Table 121. Dalton Pharma Business Overview
Table 122. Dalton Pharma Clinical Research Organisation (CRO) Product and Services
Table 123. Dalton Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 124. Dalton Pharma Recent Developments
Table 125. NovAliX Company Details
Table 126. NovAliX Business Overview
Table 127. NovAliX Clinical Research Organisation (CRO) Product and Services
Table 128. NovAliX Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 129. NovAliX Recent Developments
Table 130. Jubilant Biosys Company Details
Table 131. Jubilant Biosys Business Overview
Table 132. Jubilant Biosys Clinical Research Organisation (CRO) Product and Services
Table 133. Jubilant Biosys Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 134. Jubilant Biosys Recent Developments
Table 135. Lupin Pharmaceuticals Company Details
Table 136. Lupin Pharmaceuticals Business Overview
Table 137. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Services
Table 138. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 139. Lupin Pharmaceuticals Recent Developments
Table 140. Piramal Pharma Company Details
Table 141. Piramal Pharma Business Overview
Table 142. Piramal Pharma Clinical Research Organisation (CRO) Product and Services
Table 143. Piramal Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 144. Piramal Pharma Recent Developments
Table 145. Sun Pharmaceutical Company Details
Table 146. Sun Pharmaceutical Business Overview
Table 147. Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Services
Table 148. Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 149. Sun Pharmaceutical Recent Developments
Table 150. Sai Ganga Panakeia Company Details
Table 151. Sai Ganga Panakeia Business Overview
Table 152. Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Services
Table 153. Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 154. Sai Ganga Panakeia Recent Developments
Table 155. Vitas Pharma Company Details
Table 156. Vitas Pharma Business Overview
Table 157. Vitas Pharma Clinical Research Organisation (CRO) Product and Services
Table 158. Vitas Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 159. Vitas Pharma Recent Developments
Table 160. Pharmaron Beijing Company Details
Table 161. Pharmaron Beijing Business Overview
Table 162. Pharmaron Beijing Clinical Research Organisation (CRO) Product and Services
Table 163. Pharmaron Beijing Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 164. Pharmaron Beijing Recent Developments
Table 165. WuXi AppTec Company Details
Table 166. WuXi AppTec Business Overview
Table 167. WuXi AppTec Clinical Research Organisation (CRO) Product and Services
Table 168. WuXi AppTec Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 169. WuXi AppTec Recent Developments
Table 170. Asymchem Laboratories Company Details
Table 171. Asymchem Laboratories Business Overview
Table 172. Asymchem Laboratories Clinical Research Organisation (CRO) Product and Services
Table 173. Asymchem Laboratories Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 174. Asymchem Laboratories Recent Developments
Table 175. Porton Pharma Company Details
Table 176. Porton Pharma Business Overview
Table 177. Porton Pharma Clinical Research Organisation (CRO) Product and Services
Table 178. Porton Pharma Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 179. Porton Pharma Recent Developments
Table 180. ChemPartner Company Details
Table 181. ChemPartner Business Overview
Table 182. ChemPartner Clinical Research Organisation (CRO) Product and Services
Table 183. ChemPartner Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 184. ChemPartner Recent Developments
Table 185. Hangzhou Tigermed Company Details
Table 186. Hangzhou Tigermed Business Overview
Table 187. Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Services
Table 188. Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue in Clinical Research Organisation (CRO) Business (2017-2022) & (US$ Million)
Table 189. Hangzhou Tigermed Recent Developments
Table 190. Clinical Research Organisation (CRO) Market Trends
  • Global Public and Personal Safety Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
    Published: 11-Jan-2024        Price: US 5600 Onwards        Pages: 177
    The global Public and Personal Safety Industry market size was US$ 6,398.95 million in 2022 and is forecast to a readjusted size of US$ 18,265.36 million by 2029 with a CAGR of 16.88% during the forecast period 2023-2029. The global key companies of Public and Personal Safety Industry include Hexagon, Motorola Solutions Inc, NEC, Tyler Technologies Inc and Indra Sistemas, accounting for 24.50% market share in terms of revenues in 2022. The market research report offered here is a v......
  • Global Digital Watermark Technology Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global market for Digital Watermark Technology estimated was at US$ 111.3 million in the year 2022, is projected to reach a revised size of US$ 210.53 million by 2029, growing at a CAGR of 9.4% during the forecast period 2023-2029. North American market for Digital Watermark Technology was valued at $ 39.07 million in 2022 and will reach $ 68.79 million by 2029, at a CAGR of 8.2 % during the forecast period of 2023 through 2029. Asia-Pacific market for Digital Watermark Technol......
  • Global Location Based Marketing Services Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Location Based Marketing Services market was valued at US$ 46700 million in 2023 and is anticipated to reach US$ 144870 million by 2030, witnessing a CAGR of 17.2% during The forecast period 2024-2030. North American market for Location Based Marketing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Location Based Marketing Services is estima......
  • Global Auto Repair and Beauty Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 72
    The global Auto Repair and Beauty market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Automotive is a key driver of this industry. According to data from The World Automobile Organization (OICA), global automobile production and sales in 2017 reached their peak in The past 10 years, at 97.3 million and 95.89 million respectively. In 2018, The global economic expansion ended, and The gl......
  • Global Viral Vector Development Service Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global Viral Vector Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Viral Vector Development Service is estimated to increase from......
  • Global Building Automation Systems (BAS) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Building Automation Systems (BAS) market was valued at US$ 75680 million in 2023 and is anticipated to reach US$ 143970 million by 2030, witnessing a CAGR of 9.5% during The forecast period 2024-2030. North American market for Building Automation Systems (BAS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Building Automation Systems (BAS) is estimat......
  • Global SLAM in Mobile Robots and Smart AR Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    This report studies The SLAM Robots market, Simultaneous localization and mapping, or SLAM for short, is The process of creating a map using a robot or unmanned vehicle that navigates that environment while using The map it generates. SLAM is technique behind robot mapping or robotic cartography. The robot or vehicle plots a course in an area, but at The same time, it also has to figure out where its own self is located in The place. The process of SLAM uses a complex array of computations, algo......
  • Global Digital Educational Publishing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Digital Educational Publishing market was valued at US$ 8324.5 million in 2023 and is anticipated to reach US$ 14580 million by 2030, witnessing a CAGR of 7.9% during The forecast period 2024-2030. North American market for Digital Educational Publishing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Digital Educational Publishing is estimated to inc......
  • Global Human Source Service Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The global Human Source Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Human Source Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Human Source Service is estimated to increase from $ million in 2023 to reach $ millio......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs